BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 25707922)

  • 1. Cisplatin-loaded polymeric nanoparticles: characterization and potential exploitation for the treatment of non-small cell lung carcinoma.
    Shi C; Yu H; Sun D; Ma L; Tang Z; Xiao Q; Chen X
    Acta Biomater; 2015 May; 18():68-76. PubMed ID: 25707922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics, biodistribution and in vivo efficacy of cisplatin loaded poly(L-glutamic acid)-g-methoxy poly(ethylene glycol) complex nanoparticles for tumor therapy.
    Yu H; Tang Z; Zhang D; Song W; Zhang Y; Yang Y; Ahmad Z; Chen X
    J Control Release; 2015 May; 205():89-97. PubMed ID: 25529533
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methoxypoly(ethylene glycol)-block-poly(L-glutamic acid)-loaded cisplatin and a combination with iRGD for the treatment of non-small-cell lung cancers.
    Song W; Li M; Tang Z; Li Q; Yang Y; Liu H; Duan T; Hong H; Chen X
    Macromol Biosci; 2012 Nov; 12(11):1514-23. PubMed ID: 23070837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cisplatin Loaded Poly(L-glutamic acid)-g-Methoxy Poly(ethylene glycol) Complex Nanoparticles for Potential Cancer Therapy: Preparation, In Vitro and In Vivo Evaluation.
    Yu H; Tang Z; Li M; Song W; Zhang D; Zhang Y; Yang Y; Sun H; Deng M; Chen X
    J Biomed Nanotechnol; 2016 Jan; 12(1):69-78. PubMed ID: 27301173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic Antitumor Efficacy Mediated by Liposomal Co-Delivery of Polymeric Micelles of Vinorelbine and Cisplatin in Non-Small Cell Lung Cancer.
    Wang S; Gou J; Wang Y; Tan X; Zhao L; Jin X; Tang X
    Int J Nanomedicine; 2021; 16():2357-2372. PubMed ID: 33790554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cisplatin loaded methoxy poly (ethylene glycol)-block-Poly (L-glutamic acid-co-L-Phenylalanine) nanoparticles against human breast cancer cell.
    Ahmad Z; Tang Z; Shah A; Lv S; Zhang D; Zhang Y; Chen X
    Macromol Biosci; 2014 Sep; 14(9):1337-45. PubMed ID: 24933015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Co-delivery of polymeric metformin and cisplatin by self-assembled core-membrane nanoparticles to treat non-small cell lung cancer.
    Xiong Y; Zhao Y; Miao L; Lin CM; Huang L
    J Control Release; 2016 Dec; 244(Pt A):63-73. PubMed ID: 27840166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual-responsive mPEG-PLGA-PGlu hybrid-core nanoparticles with a high drug loading to reverse the multidrug resistance of breast cancer: an in vitro and in vivo evaluation.
    Xu H; Yang D; Cai C; Gou J; Zhang Y; Wang L; Zhong H; Tang X
    Acta Biomater; 2015 Apr; 16():156-68. PubMed ID: 25662165
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pulmonary delivery by exploiting doxorubicin and cisplatin co-loaded nanoparticles for metastatic lung cancer therapy.
    Xu C; Wang Y; Guo Z; Chen J; Lin L; Wu J; Tian H; Chen X
    J Control Release; 2019 Feb; 295():153-163. PubMed ID: 30586598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nanoscaled poly(L-glutamic acid)/doxorubicin-amphiphile complex as pH-responsive drug delivery system for effective treatment of nonsmall cell lung cancer.
    Li M; Song W; Tang Z; Lv S; Lin L; Sun H; Li Q; Yang Y; Hong H; Chen X
    ACS Appl Mater Interfaces; 2013 Mar; 5(5):1781-92. PubMed ID: 23410916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Co-delivery of cisplatin and paclitaxel by folic acid conjugated amphiphilic PEG-PLGA copolymer nanoparticles for the treatment of non-small lung cancer.
    He Z; Huang J; Xu Y; Zhang X; Teng Y; Huang C; Wu Y; Zhang X; Zhang H; Sun W
    Oncotarget; 2015 Dec; 6(39):42150-68. PubMed ID: 26517524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypeptide-based combination of paclitaxel and cisplatin for enhanced chemotherapy efficacy and reduced side-effects.
    Song W; Tang Z; Li M; Lv S; Sun H; Deng M; Liu H; Chen X
    Acta Biomater; 2014 Mar; 10(3):1392-402. PubMed ID: 24316362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A co-delivery system based on paclitaxel grafted mPEG-b-PLG loaded with doxorubicin: preparation, in vitro and in vivo evaluation.
    Li Q; Lv S; Tang Z; Liu M; Zhang D; Yang Y; Chen X
    Int J Pharm; 2014 Aug; 471(1-2):412-20. PubMed ID: 24905776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-tumor efficacy of polymer-platinum(II) complex micelles fabricated from folate conjugated PEG-graft-α,β-poly [(N-amino acidyl)-aspartamide] and cis-dichlorodiammine platinum(II) in tumor-bearing mice.
    Xue Y; Tang X; Huang J; Zhang X; Yu J; Zhang Y; Gui S
    Colloids Surf B Biointerfaces; 2011 Jul; 85(2):280-8. PubMed ID: 21435846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-tumor efficacy of c(RGDfK)-decorated polypeptide-based micelles co-loaded with docetaxel and cisplatin.
    Song W; Tang Z; Zhang D; Zhang Y; Yu H; Li M; Lv S; Sun H; Deng M; Chen X
    Biomaterials; 2014 Mar; 35(9):3005-14. PubMed ID: 24388813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intratumoral injection of gels containing losartan microspheres and (PLG-g-mPEG)-cisplatin nanoparticles improves drug penetration, retention and anti-tumor activity.
    Yu M; Zhang C; Tang Z; Tang X; Xu H
    Cancer Lett; 2019 Feb; 442():396-408. PubMed ID: 30439541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hemocompatibility of folic-acid-conjugated amphiphilic PEG-PLGA copolymer nanoparticles for co-delivery of cisplatin and paclitaxel: treatment effects for non-small-cell lung cancer.
    He Z; Shi Z; Sun W; Ma J; Xia J; Zhang X; Chen W; Huang J
    Tumour Biol; 2016 Jun; 37(6):7809-21. PubMed ID: 26695149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-delivery of gemcitabine and cisplatin via Poly (L-glutamic acid)-g-methoxy poly (ethylene glycol) micelle to improve the in vivo stability and antitumor effect.
    Ding N; Zhao Z; Yin N; Xu Y; Yin T; Gou J; He H; Wang Y; Zhang Y; Tang X
    Pharm Res; 2021 Dec; 38(12):2091-2108. PubMed ID: 34893950
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a novel biocompatible poly(ethylene glycol)-block-poly(γ-cholesterol-L-glutamate) as hydrophobic drug carrier.
    Ma Q; Li B; Yu Y; Zhang Y; Wu Y; Ren W; Zheng Y; He J; Xie Y; Song X; He G
    Int J Pharm; 2013 Mar; 445(1-2):88-92. PubMed ID: 23376505
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Doxorubicin-loaded amphiphilic polypeptide-based nanoparticles as an efficient drug delivery system for cancer therapy.
    Lv S; Li M; Tang Z; Song W; Sun H; Liu H; Chen X
    Acta Biomater; 2013 Dec; 9(12):9330-42. PubMed ID: 23958784
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.